Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer
- DOI
- 10.1158/0008-5472.can-24-3478
- Published
- 2025-05-19
- Container
- Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/0008-5472.can-24-3478,
title = {Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer},
author = {Stephen L. DeAngelo and Liang Zhao and Sofia Dziechciarz and Myungsun Shin and Sumeet Solanki and Andrii Balia and Marwa O. El-Derany and Cristina Castillo and Yao Qin and Nupur K. Das and Hannah N. Bell and Joao A. Paulo and Yuezhong Zhang and Nicholas J. Rossiter and Elizabeth C. McCulla and Jianping He and Indrani Talukder and Billy Wai-Lung Ng and Zachary T. Schafer and Nouri Neamati and Joseph D. Mancias and Markos Koutmos and Yatrik M. Shah},
year = {2025},
journal = {Cancer Research},
doi = {10.1158/0008-5472.can-24-3478},
url = {https://doi.org/10.1158/0008-5472.can-24-3478}
}RIS
TY - JOUR TI - Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer AU - Stephen L. DeAngelo AU - Liang Zhao AU - Sofia Dziechciarz AU - Myungsun Shin AU - Sumeet Solanki AU - Andrii Balia AU - Marwa O. El-Derany AU - Cristina Castillo AU - Yao Qin AU - Nupur K. Das AU - Hannah N. Bell AU - Joao A. Paulo AU - Yuezhong Zhang AU - Nicholas J. Rossiter AU - Elizabeth C. McCulla AU - Jianping He AU - Indrani Talukder AU - Billy Wai-Lung Ng AU - Zachary T. Schafer AU - Nouri Neamati AU - Joseph D. Mancias AU - Markos Koutmos AU - Yatrik M. Shah PY - 2025 JO - Cancer Research DO - 10.1158/0008-5472.can-24-3478 UR - https://doi.org/10.1158/0008-5472.can-24-3478 ER -
APA
DeAngelo, S. L., Zhao, L., Dziechciarz, S., Shin, M., Solanki, S., Balia, A., El-Derany, M. O., Castillo, C., Qin, Y., Das, N. K., Bell, H. N., Paulo, J. A., Zhang, Y., Rossiter, N. J., McCulla, E. C., He, J., Talukder, I., Ng, B. W., Schafer, Z. T., Neamati, N., Mancias, J. D., Koutmos, M., & Shah, Y. M. (2025). Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-24-3478
Source records
- crossref · retrieved 2026-09-26T06:11:03.867Z